| Active ingredients | Status | Update | Specialty |
| dopamine (hydrochloride) | Supply tension | 14/11/2025 | Dopamine Viatris 40 mg/mL, solution for infusion |
| dipotassium clorazepate | Stock shortage | 14/11/2025 | Tranxene 20 mg/2 mL, lyophilisate and solution for parenteral use |
| cyamemazine | Stock shortage | 14/11/2025 | Tercian 50 mg/5 mL, injectable solution in ampoule |
| temozolomide | Return to availability | 14/11/2025 | Temodal 2.5 mg/mL, powder for solution for infusion |
| propofol | Return to availability | 14/11/2025 | Diprivan 20 mg/mL, injectable emulsion in pre-filled syringe |
| propofol | Return to availability | 14/11/2025 | Diprivan 10 mg/mL, injectable emulsion in pre-filled syringe |
| megestrol (acetate) | Stock shortage | 13/11/2025 | Megace 160 mg, tablet |
| methylphenidate (hydrochloride) | Supply tension | 13/11/2025 | Methylphenidate EG LP 18 mg and 36 mg, extended-release tablet |
| fluorouracil | Supply tension | 13/11/2025 | Fluorouracil Pfizer 50 mg/mL, solution for dilution for infusion – 20 mL and 100 mL vials |
| valproic acid, sodium (valproate) | Supply tension | 13/11/2025 | Micropakine L.P., extended-release granules in single-dose sachets |
| tolvaptan | Stock shortage | 10/11/2025 | Tolvaptan Biogaran 15 mg, tablet + Tolvaptan Biogaran 45 mg, tablet – |
| tolvaptan | Stock shortage | 10/11/2025 | Tolvaptan Teva 15 mg tablet + Tolvaptan Teva 45 mg tablet |
2025年11月18日